Home » Topics » BioWorld

BioWorld
RSS

WHAT'S BEHIND NIH'S PATENT QUEST

Oct. 23, 1991

REPLIGEN REACQUIRES MABS FROM MERCK

Oct. 23, 1991

ONCOTECH CUTS PRICES ON CANCER TESTS

Oct. 22, 1991

KININ BLOCKERS vs. SEPTIC SHOCK

Oct. 22, 1991

PATENT TRIAL RESCHEDULED

Oct. 22, 1991

IDEXX BUYS DIAGNOSTICS BUSINESS

Oct. 22, 1991

ANTISENSE RNA STOPS RIPENING

Oct. 22, 1991

FACTOR VIII MAb HELPS SUPPRESS AIDS

Oct. 22, 1991

HUMAN TESTS OF BIOCINE'S AIDS VACCINE

Oct. 22, 1991

SKIN REPLACEMENT TESTS SHOW PROMISE

Oct. 22, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...